Marinus製藥 MRNS 深 滬
等待開盤 08-19 09:30:00 美东时间
0.55
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.55
- 總市值 3037.02万
- 52周最高 10.50
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.2202
- 委 比 0.00%
- 總股本 5521.85万
- 歷史最高 82.88
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.2202
- 每 手 1
- 風險率 0.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Delisting of Securities from The Nasdaq Stock Market
The Nasdaq Stock Market announced on July 11, 2025, that it will delist the securities of multiple companies, including NKGen Biotech, Inc., Aquaron Acquisition Corp., Bannix Acquisition Corp., Avenue Therapeutics, Inc., WinVest Acquisition Corp., IMAC Holdings, Inc., Lytus Technologies Holdings PTV Ltd., Luokung Technology Corp., Aptose Biosciences, Inc., Virpax Pharmaceuticals, Inc., Phoenix Motor Inc., Denali Capital Acquisition Corp., Thunder...
07-11 20:05
快讯 | Marinus Pharmaceuticals Inc : Baird 将目标价从 $0.50 上调至 $0.55
Marinus Pharmaceuticals Inc : Baird Raises Target Price to $0.55 From $0.50
2024-12-31 12:06
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders
NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2024-12-31 02:37
全球罕见病公司Immedica拟现金收购Marinus Pharmaceuticals(MRNS.US)
全球罕见病公司Immedica Pharma将通过收购要约和随后合并收购Marinus，截至发稿，Marinus 股价周一盘前大涨44%。
2024-12-30 20:46
Marinus Ends Agreements Amid Strategic Review
Marinus ( ($MRNS) ) has issued an announcement. Marinus Pharmaceuticals has ter...
2024-12-30 20:29
Marinus Pharmaceuticals Merges with Immedica Pharma AB
Marinus ( ($MRNS) ) has provided an announcement. Marinus Pharmaceuticals has e...
2024-12-30 20:28
Immedica to buy Marinus Pharmaceuticals, stock rises 4%
Immedica Pharma AB, a global rare disease company will acquire Marinus Pharmaceuticals (NASDAQ:MRNS) by means of a tender offer and subsequent merger. The acquisition complements and further strengthe...
2024-12-30 20:08
Immedica Pharma to Acquire Marinus Pharmaceuticals in Strategic Merger For $0.55/Share Implying An Enterprise Value Of $151M
Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today
2024-12-30 20:04
Marinus Unveils Management Retention and Severance Plans
The latest update is out from Marinus ( ($MRNS) ). Marinus Pharmaceuticals has ...
2024-12-24 05:33
Marinus Pharmaceuticals Faces Financial Turmoil Amidst Class Action Lawsuit
Marinus Pharmaceuticals Inc (MRNS) has disclosed a new risk, in the Litigation ...
2024-11-14 14:00
